TABLE 1.
Study | Outcome | Sample size | Data source and study design | Demographics | Socioeconomic status | |||
---|---|---|---|---|---|---|---|---|
Mean age | Female sex (%) | Race and ethnicity (%) | Insurance (%) | Education (%) | ||||
2010, Friedman | Perioperative complications | 6320 | Cross‐sectional analysis using discharge data (1995–2005) from the HCUP‐NIS, ICD‐9 diagnostic, and procedure codes (1999–2005) from cases of patients undergoing LKD. Mean LOS: 3.3 days | 40 | 59 |
n = 4329 Hispanic: 11 Black: 12 Other▪: 6 White: 68 |
n = 6210 Private: 44 Self‐Pay: 13 Medicare: 13 Medicaid 2 No charge 1 Other: 26 |
NR |
2010, Lentine ◊ | CKD, CVD, DM, HTN | 4650 |
Linkage of OPTN data (1987–2007) with administrative billing claims from a private health insurer (2000–2007) CKD outcome evaluated among coding subgroup of 2307 LKDs. Median follow‐up: 7.7 yrs |
37 | 55 |
Hispanic: 8.2 Non‐Hispanic Black: 13.1 Non‐Hispanic White: 76.3 Other▪: 2.4 |
Private: 100 |
n = 3385
<12th grade
|
2010, Segev | Mortality | 80 347 | Linkage of OPTN LKD data (1994–2009) and SSDMF. Median follow‐up: 6.3 yrs | 18–39: 49 40–49: 30 50–59: 17 ≥60: 4 | 59 |
n = 80 286 Hispanic: 12.3 Black: 13.1 Other□: 1.6 White: 73.1 |
NR |
n = 41 146 GS: 2 HS: 36 Some college: 28 College graduate: 24 Post‐college: 10 |
2011, Lentine ◊ | DM, HTN (accounted for relatedness to recipient) | 4650 | Linkage of OPTN data (1987–2007) with administrative billing claims from a private health insurer (2000–2007) | See Lentine 2010 | ||||
2014, Lentine Am J Nephrol ◊ | HTN | 4650 | Linkage of OPTN data (1987–2007) with administrative billing claims from a private health insurer (2000–2007), specifically using pharmacy fills | See Lentine 2010 | ||||
2014, Lentine Transp. | CKD, DM, HTN | 4007 | Linkage of OPTN data (1987–2008) with Medicare‐insured living donors. Median follow‐up: 6 yrs | 55 | 60 |
Hispanic: 5.7 Non‐Hispanic Black: 8.1 Non‐Hispanic White: 83.4 Other▪: 2.8 |
Medicare: 100 | NR |
2014, Muzaale | ESKD | 96 217 | Linkage of OPTN LKD data (1994–2011) and national kidney replacement treatment records. Healthy controls from NHANES III (screened for health exclusions to donation, matched by demographic and clinical factors) LKD. Median follow‐up: 7.6 yrs | 40 | 59 |
Hispanic: 12.5 Black: 12.9 White/other □: 74.6 |
NR |
HS or less: 36 Some college: 28 College graduate: 25 Post college: 10 |
2014, Schold | Rehospitalization | 4524 | Retrospective cohort using State Inpatient Databases compiled by AHRQ. Data from North Carolina, New York, Florida, California. Follow‐up: 731 days | 41 | n = 386160 |
n = 3395 Hispanic: 21 Black: 10 White: 63 |
NR | NR |
2015, Lam ◊ | Gout | 4650 | Linkage of OPTN data (1987–2007) with administrative billing claims from a private health insurer (2000–2007) | See Lentine 2010 | ||||
2015, Lentine ◊ |
Proteinuria Nephrotic syndrome Nephritis/nephropathy Renal failure, any kidney diagnosis, CKD (accounting for relatedness) |
4650 | Linkage of OPTN data (1987–2007) with administrative billing claims from a private health insurer (2000–2007) | See Lentine 2010 | ||||
2016, Anjum |
ESKD, early (0–9 yrs), and late (10–25 yrs) post‐donation by subtype:
|
125 427 | Linkage of OPTN data (1987–2014) and national kidney replacement treatment records. Median follow‐up: 11 yrs | 40 | 59 |
Hispanic: 12 Black: 13 White or other▪: 75 |
NR |
HS or less: 35 Attended college: 28 Graduate or more: 37 |
2016, Lentine | Perioperative complications | 14 964 | Linkage of OPTN data (2008–2012) with UHC database, an alliance of 107 academic medical centers and 234 of affiliated hospitals. Follow‐up: perioperative period | 42 | 62 |
Hispanic: 11 Black: 12 Other: 5 White: 72 |
Insured: 73 Uninsured: 12 Missing: 15 |
NR |
2017, Massie | ESKD | 133 824 | Linkage of OPTN data (1987–2015) and national kidney replacement treatment records, SSDMF. Median follow‐up: NR | 40* | ESKD: 39 No ESKD: 59 |
Hispanic: % NR ESKD, Black: 34 No ESKD, Black: 13 |
NR | NR |
2018, Wainright | ESKD | 123 526 | Linkage of OPTN LKD data (1994–2016) and national kidney replacement treatment records, SSDMF. Median follow‐up: 10.3 | ESKD: 38 No ESKD: 41 | ESKD: 42 No ESKD: 60 |
ESKD
No ESKD
|
NR | NR |
2019, Holscher |
Early (within first 2 yrs post‐donation)
|
41 260 | Linkage of OPTN data (2008–2014) with OPTN living donor follow‐up form data. Max follow‐up: 2 yrs | 42* | 62 |
Hispanic ethnicity, reported separately from race: 14 Race:
|
Insured 73 Uninsured: 13 Unknown: 14 |
Some college or higher
|
2019, Lentine |
DM
|
28 515 | Retrospective cohort study using a large US pharmaceutical claims data warehouse‐ comprises National Council for Prescription Drug Program 5.1‐format prescription claims aggregated from multiple sources including data clearinghouses, retail pharmacies, and prescription benefit managers (2007 to 2016). Mean follow‐up: 3.8 yrs | 43 | 67 |
Hispanic: 12 White: 74 Black: 11 Other▪: 4 |
Insured: 79 Uninsured: 10 Unknown: 11 |
College or higher: 67 GS/HS: 25 Unknown: 8 |
2020, Muzaale | ESKD, stratified by biological relatedness | 143 750 | Linkage of OPTN LKD data (1987–2017) and national kidney replacement treatment records. Median follow‐up: 12 yrs | 40 | 59 |
Hispanic: 13 Asian: 3 Black: 12 White: 72 |
NR |
College graduate: 26 Post‐graduate education: 11 |
2021, Augustine | Change in eGFR, proteinuria | 34 504 | LKD data (2008–2014) from the SRTR registry. Max follow‐up: 2 yrs | 42 | 63 |
Hispanic: 13.7 Black: 11.0 Other▪: 4.8 White: 70.5 |
Insured: 85 |
HS or less: 29 Some college or higher: 71 |
▪ other, not explicitly defined; ◊ same cohort (original study: Lentine et al., 2010); *median; median time follow‐up from donation to the end of observed insurance benefits; □ other, defined as American Indian, Native Hawaiian, Alaskan Native, Pacific Islander, and multiracial.
Abbreviations: AHRQ, Agency for Healthcare Research and Quality; Am J Nephrol, American Journal of Nephrology; CKD, chronic kidney disease; CVD, cardiovascular disease; DM, diabetes mellitus; ESKD, end‐stage kidney disease; GN, glomerulonephritis, eGFR, estimated glomerular filtration rate; GS, grade school; HCUP‐NIS, Healthcare Cost and Utilization Project‐National (Nationwide) Inpatient Sample; HS, high school; HTN, hypertension; LKD, living kidney donor; LOS, length of stay; NHANES, National Health and Nutrition Examination Survey; NR, not reported; OPTN, Organ Procurement and Transplantation Network; SRTR, Scientific Registry of Transplant Recipients; SSDMF, Social Security Death Master File; Transp, Transplantation; yrs, years.